A H2S-Nampt dependent energetic circuit is critical to survival and cytoprotection from damage in cancer cells.

A H2S-Nampt dependent energetic circuit is critical to survival and cytoprotection from damage in cancer cells.
复制标题

DOI:
10.1371/journal.pone.0108537
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Tabibzadeh S
Tabibzadeh S
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Sanokawa-Akakura R;Ostrakhovitch EA;Akakura S;Goodwin S;Tabibzadeh S

文献摘要

参考文献

被引文献

相似文献

We recently demonstrated that cancer cells that recover from damage exhibit increased aerobic glycolysis, however, the molecular mechanism by which cancer cells survive the damage and show increased aerobic glycolysis remains unknown. Here, we demonstrate that diverse cancer cells that survive hypoxic or oxidative damage show rapid cell proliferation, and develop tolerance to damage associated with increased production of hydrogen sulfide (H2S) which drives up-regulation of nicotinamide phosphoribosyltransferase (Nampt). Consistent with existence of a H2S-Nampt energetic circuit, in damage recovered cancer cells, H2S, Nampt and ATP production exhibit a significant correlation. Moreover, the treatment of cancer cells with H2S donor, NaHS, coordinately increases Nampt and ATP levels, and protects cells from drug induced damage. Inhibition of cystathionine beta synthase (CBS) or cystathionase (CTH), enzymes which drive generation of H2S, decreases Nampt production while suppression of Nampt pathway by FK866, decreases H2S and ATP levels. Damage recovered cells isolated from tumors grown subcutaneously in athymic mice also show increased production of H2S, Nampt and ATP levels, associated with increased glycolysis and rapid proliferation. Together, these data show that upon recovery from potential lethal damage, H2S-Nampt directs energy expenditure and aerobic glycolysis in cancer cells, leads to their exponential growth, and causes a high degree of tolerance to damage. Identification of H2S-Nampt as a pathway responsible for induction of damage tolerance in cancer cells may underlie resistance to therapy and offers the opportunity to target this pathway as a means in treatment of cancer.
DOI: 10.1073/pnas.0705891104
发表时间: 2007-09-25
影响因子: 11.1
作者:
Elrod, John W.;Calvert, John W.;Lefer, David J.
通讯作者: Lefer, David J.
DOI: 10.1096/fj.04-1815fje
发表时间: 2004-05-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Kimura, Y;Kimura, H
通讯作者: Kimura, H
DOI: 10.2307/3572022
发表时间: 1966-01-01
期刊: RADIATION RESEARCH
影响因子: 3.4
作者:
PHILLIPS, RA;TOLMACH, LJ
通讯作者: TOLMACH, LJ
DOI: 10.1371/journal.pone.0025921
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Lan A;Liao X;Mo L;Yang C;Yang Z;Wang X;Hu F;Chen P;Feng J;Zheng D;Xiao L
通讯作者: Xiao L
DOI: 10.1089/ars.2009.2915
发表时间: 2010-05-01
影响因子: 6.6
作者:
Cao, Qiuhui;Zhang, Li;Wang, Rui
通讯作者: Wang, Rui